|
1
|
Libby P, Ridker PM and Hansson GK:
Progress and challenges in translating the biology of
atherosclerosis. Nature. 473:317–325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Doran AC, Meller N and McNamara CA: Role
of smooth muscle cells in the initiation and early progression of
atherosclerosis. Arterioscler Thromb Vasc Biol. 28:812–819. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
King RW, Jackson PK and Kirschner MW:
Mitosis in transition. Cell. 79:563–571. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weiss D, Sorescu D and Taylor WR:
Angiotensin II and atherosclerosis. Am J Cardiol. 87:25C–32C. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mehta PK and Griendling KK: Angiotensin II
cell signaling: physiological and pathological effects in the
cardiovascular system. Am J Physiol Cell Physiol. 292:C82–C97.
2007. View Article : Google Scholar
|
|
6
|
Klein EA and Assoian RK: Transcriptional
regulation of the cyclin D1 gene at a glance. J Cell Sci.
121:3853–3857. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen Z, Zang J, Kappler J, Hong X,
Crawford F, Wang Q, Lan F, Jiang C, Whetstine J, Dai S, et al:
Structural basis of the recognition of a methylated histone tail by
JMJD2A. Proc Natl Acad Sci USA. 104:10818–10823. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Whetstine JR, Nottke A, Lan F, Huarte M,
Smolikov S, Chen Z, Spooner E, Li E, Zhang G, Colaiacovo M and Shi
Y: Reversal of histone lysine trimethylation by the JMJD2 family of
histone demethylases. Cell. 125:467–481. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang J, Chen J, Yang J, Xu C, Ding J,
Yang J, Guo Q, Hu Q and Jiang H: Sodium ferulate inhibits
neointimal hyperplasia in rat balloon injury model. PLoS One.
9:e875612014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shin S and Janknecht R: Activation of
androgen receptor by histone demethylases JMJD2A and JMJD2D.
Biochem Biophys Res Commun. 359:742–746. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kogure M, Takawa M, Cho HS, Toyokawa G,
Hayashi K, Tsunoda T, Kobayashi T, Daigo Y, Sugiyama M, Atomi Y, et
al: Deregulation of the histone demethylase JMJD2A is involved in
human carcinogenesis through regulation of the G(1)/S transition.
Cancer Lett. 336:76–84. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ding X, Pan H, Li J, Zhong Q, Chen X, Dry
SM and Wang CY: Epigenetic activation of AP1 promotes squamous cell
carcinoma metastasis. Sci Signal. 6:ra282013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Berry WL, Shin S, Lightfoot SA and
Janknecht R: Oncogenic features of the JMJD2A histone demethylase
in breast cancer. Int J Oncol. 41:1701–1706. 2012.PubMed/NCBI
|
|
14
|
Kauffman EC, Robinson BD, Downes MJ,
Powell LG, Lee MM, Scherr DS, Gudas LJ and Mongan NP: Role of
androgen receptor and associated lysine-demethylase coregulators,
LSD1 and JMJD2A, in localized and advanced human bladder cancer.
Mol Carcinog. 50:931–944. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim TD, Shin S, Berry WL, Oh S and
Janknecht R: The JMJD2A demethylase regulates apoptosis and
proliferation in colon cancer cells. J Cell Biochem. 113:1368–1376.
2012. View Article : Google Scholar
|
|
16
|
Gray SG, Iglesias AH, Lizcano F,
Villanueva R, Camelo S, Jingu H, Teh BT, Koibuchi N, Chin WW,
Kokkotou E and Dangond F: Functional characterization of JMJD2A, a
histone deacetylase- and retinoblastoma-binding protein. J Biol
Chem. 280:28507–28518. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang D, Yoon HG and Wong J: JMJD2A is a
novel N-CoR-interacting protein and is involved in repression of
the human transcription factor achaete scute-like homologue 2
(ASCL2/Hash2). Mol Cell Biol. 25:6404–6414. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Villeneuve LM, Reddy MA, Lanting LL, Wang
M, Meng L and Natarajan R: Epigenetic histone H3 lysine 9
methylation in metabolic memory and inflammatory phenotype of
vascular smooth muscle cells in diabetes. Proc Natl Acad Sci USA.
105:9047–9052. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weng X, Cheng X, Wu X, Xu H, Fang M and Xu
Y: Sin3B mediates collagen type I gene repression by interferon
gamma in vascular smooth muscle cells. Biochem Biophys Res Commun.
447:263–270. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lockman K, Taylor JM and Mack CP: The
histone demethylase, Jmjd1a, interacts with the myocardin factors
to regulate SMC differentiation marker gene expression. Circ Res.
101:e115–e123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen D, Liu J, Rui B, Gao M, Zhao N, Sun
S, Bi A, Yang T, Guo Y, Yin Z and Luo L: GSTpi protects against
angiotensin II-induced proliferation and migration of vascular
smooth muscle cells by preventing signal transducer and activator
of transcription 3 activation. Biochim Biophys Acta. 1843:454–463.
2014. View Article : Google Scholar
|
|
22
|
Kim JE and Choi HC: Losartan inhibits
vascular smooth muscle cell proliferation through activation of
AMP-activated protein kinase. Korean J Physiol Pharmacol.
14:299–304. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Molenaar JJ, Ebus ME, Koster J, van Sluis
P, van Noesel CJ, Versteeg R and Caron HN: Cyclin D1 and CDK4
activity contribute to the undifferentiated phenotype in
neuroblastoma. Cancer Res. 68:2599–2609. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsaousi A, Williams H, Lyon CA, Taylor V,
Swain A, Johnson JL and George SJ: Wnt4/β-catenin signaling induces
VSMC proliferation and is associated with intimal thickening. Circ
Res. 108:427–436. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Musgrove EA: Cyclins: roles in mitogenic
signaling and oncogenic transformation. Growth Factors. 24:13–19.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lachner M, O'Carroll D, Rea S, Mechtler K
and Jenuwein T: Methylation of histone H3 lysine 9 creates a
binding site for HP1 proteins. Nature. 410:116–120. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shen Q, Uray IP, Li Y, Krisko TI, Strecker
TE, Kim HT and Brown PH: The AP-1 transcription factor regulates
breast cancer cell growth via cyclins and E2F factors. Oncogene.
27:366–377. 2008. View Article : Google Scholar
|
|
28
|
Shaulian E and Karin M: AP-1 as a
regulator of cell life and death. Nat Cell Biol. 4:E131–E136. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schiller R, Scozzafava G, Tumber A,
Wickens JR, Bush JT, Rai G, Lejeune C, Choi H, Yeh TL, Chan MC, et
al: A cell-permeable ester derivative of the JmjC histone
demethylase inhibitor IOX1. ChemMedChem. 9:566–571. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
King ON, Li XS, Sakurai M, Kawamura A,
Rose NR, Ng SS, Quinn AM, Rai G, Mott BT, Beswick P, et al:
Quantitative high-throughput screening identifies
8-hydroxyquinolines as cell-active histone demethylase inhibitors.
PLoS One. 5:e155352010. View Article : Google Scholar : PubMed/NCBI
|
